Patients of childbearing/reproductive potential should use adequate birth control measures during the whole duration of study treatment.
Written informed consent according to ICH/EU Good Clinical Practice, and national/local regulations
You may not be if
Pregnancy or lactation
Specific contraindications to BEACOPPesc therapy, including:
Poorly controlled diabetes mellitus
HIV infection,
Chronic active hepatitis B and/or hepatitis C
Concomitant or previous malignancies with the exception of basal cell skin tumors, adequately treated carcinoma in situ of the cervix and any cancer that has been in complete remission for \>5 years
Psychological, familial, sociological or geographical condition potentially hampering compliance with the study protocol and follow-up schedule; those conditions should be discussed with the patient before registration in the trial
Clareo Health | Very Early FDG-PET/CT-response Adapted Therapy for Advanced Hodgkin Lymphoma (H11)
